kentucky glp-1 gastric intestinal obstruction law firm stasis attorney kentucky glp-1 stomach paralysis lawsuit kentucky semaglutide gastrointestinal lawyer Ozempic Stomach Paralysis Lawsuit kentucky glp-1 gastrointestinal obstruction law

Description

Introduction Evidence from observational studies shows that use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with various health benefits,1 including reduced risks of incident alcohol use disorder23 and incident cannabis use disorder4 and reduced frequency of healthcare encounters for tobacco use disorder.5 However, much less is known about the association between GLP-1 receptor agonists and risks of developing other substance use disorders (SUDs), such as opioid use disorder and stimulant use disorder.6 Observational studies within populations with a pre-existing SUD have also emerged suggesting that use of GLP-1 receptor agonists is associated with reduced risks of adverse events such as opioid overdose,78 alcohol intoxication,7 and risk of hospital admission for alcohol use disorder.9 While the evidence base is growing, it does not comprehensively include all common SUDs

If you or a loved one were diagnosed with non-arteritic anterior ischemic optic neuropathy or NAION after taking Ozempic, Wegovy, semaglutide or other GLP-1 receptor agonist medications, you may be entitled to compensation from a NAION lawsuit or settlement

Instead, its about making sure the right person gets the right care, at the right dose, for the right amount of time

Look at the histamine biochemical pathways and youll see why the enzyme supplement DAO (diamine-oxidase) helps many people with their symptoms of histamine intolerance (HIT)